Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:pirfenidone
|
| gptkbp:approvalYear |
2008
|
| gptkbp:approvedBy |
gptkb:Japan
|
| gptkbp:ATCCode |
gptkb:L04AX05
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pirespa
|
| gptkbp:manufacturer |
gptkb:Shionogi_&_Co.,_Ltd.
|
| gptkbp:mechanismOfAction |
anti-inflammatory
antifibrotic |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
fatigue rash |
| gptkbp:usedFor |
idiopathic pulmonary fibrosis
|
| gptkbp:bfsParent |
gptkb:pirfenidone
|
| gptkbp:bfsLayer |
8
|